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Many rural areas in Ireland, like the United King- I agree with authors that this process should be
undertaken on a regular basis in a ‘‘blame-free’’ en-dom, are remote from large vascular units and have
large elderly populations with a high incidence of vironment. In reality, all surgeons should now be
trained to deliver the best quality of clinical care, givenvascular disease. Non-specialist vascular units can
only be justified in these areas provided the results the improved structure of surgical training. It is those
same surgeons, trained in tertiary centres under theobtained are on par with larger centres.
We are currently evaluating our results of extra- supervision of experts, that now are operating in dis-
trict hospitals serving a sometimes skewed sample ofcranial vascular reconstruction from a similar non-
specialist setting using POSSUM and P-POSSUM as the population. Cook et al. has noted that 14% of
patients fell within the high-risk category (>50% mor-predictors of outcome. The number of cases performed
per year does not necessarily indicate excellence.3 Non- tality predicted) at a district hospital compared with
only 8% at a teaching hospital.4specialist vascular surgery units, in particular, must
be the subjects of regular and transparent audit in So why should a difference in morbidity and mor-
tality outcome still exist among us? The current at-order to justify their existence and the service they
give to their local population. tempts by the surgical community to answer such
questions seems vital. I recommend that we should
P. Brady and W. Joyce identify potentially confounding variables before ad-
opting additional predictive variables. We should alsoCavan, Ireland
doi:10.1053/ejvs.2001.1505, recognise surgical errors as an important variable,
with the potential for improved performance throughavailable online at http://www.idealibrary.com on
critical incident reporting. Toni Lerut, President of the
European Surgical Association, has stated that ‘‘the
quality of surgical training is the single most importantReferences
factor in reducing intra-surgeon variation’’.5 A well-
trained and well-supervised trainee should obtain1 Shuhaiber JH, Hankins M, Robless P, Whitehead SM. POSSUM
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erans Administration National Surgical Quality
Improvement Program in North America as a more
comprehensive model regarding case mix adjustment Haemorrhage Associated with Combined
Clopidogrel and Aspirin Therapybut which scoring system to use remains a dilemma.3
Nonetheless, the overall purpose of any scoring system
Sir,is the accurate prediction of outcome, which could
influence treatment decisions and rationalise resources. Antiplatelet therapy with clopidogrel (PlavixTM) is at
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least as good as aspirin in reducing the risk of isch- References
aemic events in patients with coronary, carotid and
1 Caprie Steering Committee. A randomised, blinded, trial ofperipheral vascular disease, with the advantage of
clopidogrel versus aspirin in patients at risk of ischaemic events.fewer gastrointestinal side effects.1 Combined therapy Lancet 1996; 348: 1329–1339.
2 Jauhar R, Bergman G, Savino S, et al. Effectiveness of aspirinusing clopidogrel and aspirin further reduces the risk
and clopidogrel combination therapy in coronary stenting. Am Jof thrombosis and re-occlusion after percutaneous cor-
Cardiol 1999; 84: 726–728.onary artery stenting.2 A recent adverse event has
caused us concern with regard to the increased use of
such combined therapy. The elective repair of an 8 cm
infrarenal abdominal aortic aneurysm in an 82-year- Editor’s Comment
old man was complicated by early, diffuse haem-
orrhage that failed to respond to protamine, whole The Editor is aware of at least two other cases where
combined aspirin and clopidogrel therapy caused ex-blood, platelets, and FFP. A degree of control was
finally achieved with aprotinin; but the patient died cessive blood loss during carotid endarterectomy. Vas-
cular surgeons who have also encountered thiseight days later of multiorgan failure.
We believe that combined therapy caused or con- problem should inform the relevant national regu-
latory authority. In the U.K. this is the Committee fortributed to this patient’s coagulopathy and consider
that this will be of increasing relevance as more the Safety of Medicines.
Jonathan Beardpatients are treated with this relatively new drug. We
have instituted a departmental policy concerning the Senior Editor
doi:10.1053/ejvs.2001.1506,perioperative use of combined therapy and would
be interested to hear of any similar complications available online at http://www.idealibrary.com on
experienced by colleagues in other centres.
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